General Information
Version
6.9
Revision date
2023-10-27
Product name
GLYPHOSATE-2-13C,15N
CAS No.
285978-24-7
REACH No
A
Emergency telephone
+(47)-22591300, +(47)-21930678
Icons in SDS
Company Information
company name
Merck Life Science AS
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H312, H318, H411
Hazard statements
Code
Statements
H312
Harmful in contact with skin
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008] Classification of the substance or mixture
Signal word
Danger Danger
Hazard statements
H312 Harmful in contact with skin. H318 Causes serious eye damage. H411 Toxic to aquatic life with long lasting effects. H318 Causes serious eye damage.
Precautionary statements
P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/ doctor if you feel unwell. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 Take off contaminated clothing and wash it before reuse. P391 Collect spillage. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Acute toxicity, Dermal (Category 4), H312 Serious eye damage (Category 1), H318 Long-term (chronic) aquatic hazard (Category 2), H411 For the full text of the H-Statements mentioned in this Section, see Section 16.
